medline.ch Onkologie Gynäkologische Tumoren

	Mortality prediction with adjuvant tamoxifen in breast cancer: Machine learning-integrated explainable artificial intelligence and Bayesian model results. ADMET DMPK Sridharan K, Sivaramakrishnan G. PMID: 42100630 [PubMed]
	The role of pluripotency regulators in triple-negative breast cancer immune response. Front Genet López-Santana C, Mendez-Rivera F, Bernal-Estévez DA. PMID: 42100345 [PubMed]
	SPIO-enhanced MRI for differentiating metastatic from reactive hyperplastic lymph nodes in breast cancer: diagnostic performance and association with VEGF-C expression. Front Med (Lausanne) Wu T, Wu A, Xiong H, Deng J, Zhang Z, Gong D, Luo J, Wu D. PMID: 42100288 [PubMed]
	Diagnosis and treatment of breast cancer during pregnancy: a comprehensive review. Front Med (Lausanne) Wei J, Qu F, Jiang T, Xu C. PMID: 42100272 [PubMed]
	Effect of the use of hormonal replacement therapy on breast cancer prognosis: A systematic review and meta-analysis. Oncol Lett Canelas Fernández JA, Alonso-Molero J, Rodríguez-Cundín P, Llorca J, Gómez-Acebo I, Dierssen-Sotos T. PMID: 42100024 [PubMed]
	A randomized factorial experiment to optimize the design of a culturally tailored breast cancer screening outreach chatbot intervention. Front Digit Health Langevin R, Kalidindi P, Arriaga K, Kyle RP, Akande S, Hsieh G, Marcotte LM. PMID: 42099928 [PubMed]
	Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer. Breast Cancer (Dove Med Press) Obeagu EI. PMID: 42099828 [PubMed]
	Taste alterations in breast cancer patients undergoing chemotherapy: an observational study. Front Nutr Devecchi A, Casalone V, Ponzo V, Tortarolo D, Sapino A, Bo S. PMID: 42099765 [PubMed]
	Immunotherapy innovations in triple-negative breast cancer: targeting checkpoints, combinations, and biomarkers. Oncol Rev Wang ZX, Chu JH, Wang YR, Huang LY, Qian MP. PMID: 42099744 [PubMed]
	Mitochondrial biology and immune crosstalk in breast cancer: therapeutic opportunities and challenges. Front Immunol Zeng Y, Guo Y. PMID: 42099586 [PubMed - indexed for MEDLINE]
	National Burden of Breast Cancer in Saudi Arabia, 1990-2023, With Forecasts to 2050: A Systematic Analysis for the Global Burden of Disease Study 2023. Evidance Health Sci Alalwani YJ, Alsalhi SM, Baradhwan NS, Alsubaie RM, Alhweish NA, Jarah RAA, Alsarhan LA, Albarrak RMA, Almatar ZSY, Alhajri NMF, Alshahrani RAA, AlShammari EM, Azzam AY. PMID: 42099506 [PubMed]
	Molecular understanding for therapeutic targeting of hypoxia in breast cancer. Expert Opin Ther Targets Angeli A, Supuran CT. PMID: 42099267 [PubMed - as supplied by publisher]
	Integrating Shared Decision-Making Into Breast Cancer Postmastectomy Reconstruction: A Systematic Review of Evidence, Barriers, and Real-World Implementation. Int J Cancer Maes-Carballo M, de-la-Puente-Mota N, Sampol-Ramírez L, Martínez-Martínez C, Gómez-Fandiño Y. PMID: 42098969 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Geographic Differences in Patient Experience after a Diagnosis of Lobular Breast Cancer. Ann Surg Oncol Graham-Stephenson A, Fanning CE, Geven EL, Migyanka F, Jeruss JS. PMID: 42098551 [PubMed - as supplied by publisher]
	The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study. Int J Clin Oncol Huang T, Fan Z, Wang Y, Yan X, Yang H, Wang S, Pang D, Li H, Wang H, Geng C, Huang L, Sun Y, Wang B, Sun G, Siddiqui A, Restuccia E, Shao Z. PMID: 42098463 [PubMed - as supplied by publisher]
	The impact of online-delivered controlled physical activity on cardiorespiratory fitness and heart rate variability in breast cancer survivors. Sci Rep Bohovicová L, , Bure, Palácová M, Petráková K, Gescheidtová L, , Kiss I, Bazalová P, Hrn, , Halámková J. PMID: 42098205 [PubMed - as supplied by publisher]
	A chemotherapy-free, pathological response-adapted strategy using trastuzumab-pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study. Ann Oncol Garrigós L, Ruiz-Borrego M, Pérez-García JM, Guerrero-Zotano A, Cortés-Salgado A, Kuemmel S, Colleoni M, Reboredo-Rendo C, Bermejo B, Blancas I, Gavila J, Fabi A, Morales C, Stradella A, Carañana V, Martínez-de Dueñas E, Albacar C, Ballesteros-Cidras O, Martrat G, Iacobucci S, Boix O, Berenguer-Molins P, Alcalá-López D, Cortés J, Llombart-Cussac A, PHERGain-2 investigators. PMID: 42097893 [PubMed - as supplied by publisher]
	HIV care continuity for women in postconflict Tigray: assessing mother-to-child transmission rates, infant health and cervical cancer screening. BMJ Glob Health Kebede HK, Gesesew HA, Mwanri L, Ward P. PMID: 42097707 [PubMed - indexed for MEDLINE]
	What is the adherence to an exercise intervention during (neo-)adjuvant chemotherapy among Swedish patients with breast cancer? Data from the Phys-Can randomised controlled trial. BMJ Open Henriksson A, Stenling A, Mazzoni AS, Sjövall K, Börjeson S, Berntsen S, Bean CG, Buffart LM, Nordin K, Demmelmaier I. PMID: 42097659 [PubMed - indexed for MEDLINE]
	Examining the Influence of Social Network Factors on Weight Loss Among Latina and Non-Hispanic White Breast Cancer Survivors: Observational Cohort Study. JMIR Form Res Janio E, Hoyt MA, Biegler KA, Al-Majid S, Chen Y, Kobsa A, Sorkin DH. PMID: 42097613 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 328347

Seite 1 von 16418

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung